United Capital Financial Advisers, LLC Repligen Corp Transaction History
United Capital Financial Advisers, LLC
- $13.5 Billion
- Q3 2025
A detailed history of United Capital Financial Advisers, LLC transactions in Repligen Corp stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 2,755,943 shares of RGEN stock, worth $420 Million. This represents 2.74% of its overall portfolio holdings.
Number of Shares
2,755,943Holding current value
$420 Million% of portfolio
2.74%Shares
5 transactions
Others Institutions Holding RGEN
# of Institutions
513Shares Held
54.7MCall Options Held
223KPut Options Held
673K-
Black Rock Inc. New York, NY7.57MShares$1.15 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$769 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.51MShares$534 Million0.05% of portfolio
-
State Street Corp Boston, MA1.8MShares$275 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.68MShares$257 Million0.04% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.46B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....